Skip to main content
. 2019 Oct 23;43(2):246–253. doi: 10.1007/s00270-019-02350-2

Fig. 1.

Fig. 1

Biochemical toxicities in the first three months after radioembolization. A Bilirubin measurements in mg/dl; BD Alkaline phosphatase, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in U/l. One patients developed a grade 5 REILD with deteriorating bilirubin levels (A) and increasing ALT values at 3 months (D). One patient had isolated AST elevation prior to radioembolization (C) potentially related to prior treatment with everolimus